Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

‘Standard THC units’: a proposal to standardize dose across all cannabis products and methods of administration
Tom P. Freeman, Valentina Lorenzetti
Addiction (2019) Vol. 115, Iss. 7, pp. 1207-1216
Open Access | Times Cited: 172

Showing 1-25 of 172 citing articles:

Cannabis use and cannabis use disorder
Jason P. Connor, Daniel Stjepanović, Bernard Le Foll, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 300
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis
Tom P. Freeman, Sam Craft, Jack Wilson, et al.
Addiction (2020) Vol. 116, Iss. 5, pp. 1000-1010
Open Access | Times Cited: 253
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
Abigail M. Freeman, Kat Petrilli, Rachel Lees, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 696-712
Open Access | Times Cited: 181
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update
Benedikt Fischer, Tessa Robinson, Chris Bullen, et al.
International Journal of Drug Policy (2021) Vol. 99, pp. 103381-103381
Open Access | Times Cited: 133
Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates
Jakob Manthey, Tom P. Freeman, Carolin Kilian, et al.
The Lancet Regional Health - Europe (2021) Vol. 10, pp. 100227-100227
Open Access | Times Cited: 126
Association of cannabis potency with mental ill health and addiction: a systematic review
Kat Petrilli, Shelan Ofori, Lindsey A. Hines, et al.
The Lancet Psychiatry (2022) Vol. 9, Iss. 9, pp. 736-750
Open Access | Times Cited: 126
THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 54
Cannabis and COVID-19: Reasons for Concern
Margriet van Laar, Pieter E. Oomen, Charlotte J. A. van Miltenburg, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 81
The short-term and long-term effects of cannabis on cognition: recent advances in the field
Emese Kroon, Lauren Kuhns, Janna Cousijn
Current Opinion in Psychology (2020) Vol. 38, pp. 49-55
Open Access | Times Cited: 73
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use
Valentina Lorenzetti, Chandni Hindocha, Kat Petrilli, et al.
Addiction (2021) Vol. 117, Iss. 6, pp. 1510-1517
Open Access | Times Cited: 67
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study
David Hammond, Samantha Goodman, Elle Wadsworth, et al.
International Journal of Drug Policy (2022) Vol. 105, pp. 103716-103716
Open Access | Times Cited: 64
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios
Amir Englund, Dominic Oliver, Edward Chesney, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 6, pp. 869-876
Open Access | Times Cited: 62
Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review
Corneliu N. Stanciu, Mary F. Brunette, Nikhil Teja, et al.
Psychiatric Services (2021) Vol. 72, Iss. 4, pp. 429-436
Open Access | Times Cited: 60
Using ecological momentary assessment to quantify Δ‐9‐tetrahydrocannabinol and cannabidiol use across different forms of cannabis: Feasibility in a sample of Canadian young adults reporting frequent cannabis use
Sophie G. Coelho, Sergio Rueda, Jeffrey D. Wardell
Addiction (2025)
Open Access | Times Cited: 1
Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
Grace Blest‐Hopley, Marco Colizzi, Vincent Giampietro, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 66
Blunted highs: Pharmacodynamic and behavioral models of cannabis tolerance
Johannes G. Ramaekers, Natasha L. Mason, Eef L. Theunissen
European Neuropsychopharmacology (2020) Vol. 36, pp. 191-205
Closed Access | Times Cited: 63
Factors Moderating the Association between Cannabis Use and Psychosis Risk: A Systematic Review
Sanne J. van der Steur, Albert Batalla, Matthijs G. Bossong
Brain Sciences (2020) Vol. 10, Iss. 2, pp. 97-97
Open Access | Times Cited: 62
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda
Mallory Loflin, Brian D. Kiluk, Marilyn A. Huestis, et al.
Drug and Alcohol Dependence (2020) Vol. 212, pp. 107993-107993
Open Access | Times Cited: 57
Assessment of Incorporation of Lessons From Tobacco Control in City and County Laws Regulating Legal Marijuana in California
Lynn Silver, Amanda Z. Naprawa, Alisa A. Padon
JAMA Network Open (2020) Vol. 3, Iss. 6, pp. e208393-e208393
Open Access | Times Cited: 52
Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC
Daniel J. Kruger, Jessica S. Kruger
Cannabis and Cannabinoid Research (2021) Vol. 8, Iss. 1, pp. 166-173
Closed Access | Times Cited: 47
The embodiment of wastewater data for the estimation of illicit drug consumption in Spain
Lubertus Bijlsma, Yolanda Picó, V. Andreu, et al.
The Science of The Total Environment (2021) Vol. 772, pp. 144794-144794
Open Access | Times Cited: 46
Young adult use, dual use, and simultaneous use of alcohol and marijuana: An examination of differences across use status on marijuana use context, rates, and consequences.
Alison Looby, Mark A. Prince, Margo C. Hurlocker, et al.
Psychology of Addictive Behaviors (2021) Vol. 35, Iss. 6, pp. 682-690
Open Access | Times Cited: 43
The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment
Will Lawn, Katie Trinci, Claire Mokrysz, et al.
Addiction (2023) Vol. 118, Iss. 7, pp. 1282-1294
Open Access | Times Cited: 19
Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks
Natalie Ertl, Tom P. Freeman, Claire Mokrysz, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 10, pp. 1640-1651
Open Access | Times Cited: 7
Making waves: Wastewater-based surveillance of cannabis use
Lubertus Bijlsma, Bradley S. Simpson, Cobus Gerber, et al.
Water Research (2024) Vol. 255, pp. 121522-121522
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top